Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 9Breast Neoplasms 3Cardiovascular Diseases 2Salivary Gland Adenoma, Pleomorphic 1Prostate Cancer With ≤10 Bone Metastases 1Polycystic Ovary Syndrome 1Obesity 1Non-alcoholic Fatty Liver Disease 1Metabolic Syndrome 1Metabolic Diseases 1Infertility 1Hormone-receptor-positive Breast Cancer 1Eunuchism 1Diabetes Mellitus 1Advanced Breast Cancer 1

Interventions

Toremifene 1Tamoxifen 1Ovariectomy 1Gonadotropin-Releasing Hormone 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hormone-receptor-positive Breast Cancer × Gonadotropin-Releasing Hormone × Clear all
NCT05801705 2023-05-18

Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown
700 enrolled
Breast

Hormone-receptor-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡